These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 16715371)

  • 1. Metabonomics techniques and applications to pharmaceutical research & development.
    Lindon JC; Holmes E; Nicholson JK
    Pharm Res; 2006 Jun; 23(6):1075-88. PubMed ID: 16715371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabonomics in pharmaceutical R&D.
    Lindon JC; Holmes E; Nicholson JK
    FEBS J; 2007 Mar; 274(5):1140-51. PubMed ID: 17298438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent development of metabonomics and its applications in clinical research].
    Li H; Jiang Y; He FC
    Yi Chuan; 2008 Apr; 30(4):389-99. PubMed ID: 18424407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis.
    Lindon JC; Holmes E; Bollard ME; Stanley EG; Nicholson JK
    Biomarkers; 2004; 9(1):1-31. PubMed ID: 15204308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabonomics: systems biology in pharmaceutical research and development.
    Lindon JC; Holmes E; Nicholson JK
    Curr Opin Mol Ther; 2004 Jun; 6(3):265-72. PubMed ID: 15264428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of metabonomics at the interface between drug metabolism and safety assessment.
    Waters NJ
    Curr Drug Metab; 2010 Oct; 11(8):686-92. PubMed ID: 20973758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Integration of metabonomics technology and its application in modernization of traditional Chinese medicine].
    Zhu C; Hu P; Liang QL; Wang YM; Luo GA
    Yao Xue Xue Bao; 2008 Jul; 43(7):683-9. PubMed ID: 18819470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabonomic modeling of drug toxicity.
    Keun HC
    Pharmacol Ther; 2006 Jan; 109(1-2):92-106. PubMed ID: 16051371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal pharmacometabonomics for predicting patient responses to therapy: drug metabolism, toxicity and efficacy.
    Nicholson JK; Everett JR; Lindon JC
    Expert Opin Drug Metab Toxicol; 2012 Feb; 8(2):135-9. PubMed ID: 22248264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabonomics in pharmaceutical discovery and development.
    Robertson DG; Reily MD; Baker JD
    J Proteome Res; 2007 Feb; 6(2):526-39. PubMed ID: 17269709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemometric contributions to the evolution of metabonomics: mathematical solutions to characterising and interpreting complex biological NMR spectra.
    Holmes E; Antti H
    Analyst; 2002 Dec; 127(12):1549-57. PubMed ID: 12537357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of mass spectrometry in biomarker discovery and measurement.
    Ackermann BL; Hale JE; Duffin KL
    Curr Drug Metab; 2006 Jun; 7(5):525-39. PubMed ID: 16787160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data.
    Nicholson JK; Lindon JC; Holmes E
    Xenobiotica; 1999 Nov; 29(11):1181-9. PubMed ID: 10598751
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabonomics: its potential as a tool in toxicology for safety assessment and data integration.
    Griffin JL; Bollard ME
    Curr Drug Metab; 2004 Oct; 5(5):389-98. PubMed ID: 15544433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organic chemistry in drug discovery.
    MacCoss M; Baillie TA
    Science; 2004 Mar; 303(5665):1810-3. PubMed ID: 15031494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomics and systems biology--how relevant are the developments to veterinary pharmacology, toxicology and therapeutics?
    Witkamp RF
    J Vet Pharmacol Ther; 2005 Jun; 28(3):235-45. PubMed ID: 15953196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacometabonomics and personalized medicine.
    Everett JR; Loo RL; Pullen FS
    Ann Clin Biochem; 2013 Nov; 50(Pt 6):523-45. PubMed ID: 23888060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systems biology in drug safety and metabolism: integration of microarray, real-time PCR and enzyme approaches.
    Yengi LG
    Pharmacogenomics; 2005 Mar; 6(2):185-92. PubMed ID: 15882137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty years of metabonomics: so what has metabonomics done for toxicology?
    Griffin JL
    Xenobiotica; 2020 Jan; 50(1):110-114. PubMed ID: 31826699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR-based pharmacometabonomics: A new paradigm for personalised or precision medicine.
    Everett JR
    Prog Nucl Magn Reson Spectrosc; 2017 Nov; 102-103():1-14. PubMed ID: 29157489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.